The Replicel study results people talk about are about 5 years old. And the treatment was in clinical testing before that. This means that treatment is well over 5 years old. So if their cell-based treatment works that would mean that they alone figured out a solution to the inductivity problem well over 5 years ago and for some reason they’ve been keeping that fact a secret.
I really don’t think so.
Replicel is old. I think that Replicel is part of the old wave that included Intercytex and Aderans, from back before the scientific community figured out that they have to take the inductivity problem seriously.
When Aderans and Intercytex failed they didn’t go down easy. They resisted going under but ultimately they went under. I think Replicel is going to do the same thing for the same reason - cellular loss of inductivity during culture.